Mechanism studies revealed that the concurrent targeting of CAFs and tumor cells led to an increased infiltration of CD8+ T-cells within tumors and the induction of T-cells specific to antigens that were initially absent from the vaccine [106]. This evidence concerns the gene CD8A and neoplasm.